The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
AC Immune SA(NASDAQ:ACIU) 
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, ...
Website: http://www.acimmune.com
Founded: 2003
Full Time Employees: 115
CEO / Founder: Andrea Pfeifer
Sector: Healthcare
Industry: Biotechnology
AC Immune SA Days Payable Outstanding ttm (DPO)
AC Immune SA Days Receivable Outstanding ttm (DSO)
AC Immune SA Days Inventory Outstanding ttm (DIO)
AC Immune SA Op Cashflow Per Share ttm
AC Immune SA Free Cashflow Per Share ttm
AC Immune SA Cash Per Share ttm
AC Immune SA P/S ratio ttm
AC Immune SA (GAAP) P/E ratio ttm
AC Immune SA P/B ratio ttm
No extra charts and metrics for this ticker.